Search For "antiviral drug"
Pfizer begins early stage trial for oral COVID-19 drug
Updated : 5 years, 2 months ago IST
New York [US], March 24 (ANI): Pfizer has said that it has begun early-stage clinical trials of an investigational, oral antiviral drug for Covid-19.
Read More
Study sheds light on how vitamins, steroids and potential antivirals might
Updated : 5 years, 4 months ago IST
Bristol [UK], January 29 (ANI): Evidence is emerging that vitamin D - and possibly vitamins K and A - might help combat COVID-19. A new study has shown how they - and other antiviral drugs - might work.
Read More
WHO to soon issue guidelines on use of emergency drug Remdesivir
Updated : 5 years, 7 months ago IST
Geneva [Switzerland], October 17 (ANI): The World Health Organization is set to issue policy guidelines in several weeks on the use of the antiviral drug Remdesivir, which has been given in emergency use to treat COVID-19 in several countries.
Read More
High doses of favipiravir counter SARS-CoV-2 in hamsters, Hydroxychloroqui
Updated : 5 years, 8 months ago IST
Washington [US], October 10 (ANI): Researchers report that treatment with high doses of favipiravir, an antiviral drug that has been used to treat pandemic influenza in Japan, significantly reduced SARS-CoV-2 levels in the lungs, improved lung pathology, and reduced virus transmission by dir
Read More
Telangana: 4 held for illegally procuring, selling COVID-19 antiviral drug
Updated : 5 years, 10 months ago IST
Medchal-Malkajgiri (Telangana) [India], July 20 (ANI): Four persons have been arrested on Sunday for allegedly procuring and selling of COVID-19 antiviral drugs in an illegal manner in Malkajgiri, Telangana.
Read More
Hyderabad police arrest 7 people for black marketing COVID-19 drugs
Updated : 5 years, 10 months ago IST
Hyderabad (Telangana) [India], July 18 (ANI): The Hyderabad Police arrested seven persons accused of illegally procuring and selling of COVID-19 antiviral drugs Covifor (Remdesivir) and Cipremi Injections, on Saturday.
Read More
Health ministry revises remdesivir dosage for COVID-19 patients
Updated : 5 years, 11 months ago IST
New Delhi [India], July 4 (ANI): The Union Health Ministry on Friday has revised the dosage of the antiviral drug--remdesivir, being administered to hospitalized COVID-19 patients from the earlier six-days to five-day treatment course.
Read More
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderat
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate C
Updated : 5 years, 11 months ago IST
New Delhi [India], June 20 (ANI): Domestic pharmaceuticals Glenmark on Saturday informed that their antiviral drug -- Favipiravir -- has shown clinical improvement of up to 88 per cent in mild to moderate COVID-19 cases, including those with co-morbidities.
Read More
CSIR gets nod for Phase III trial of antiviral drug Umifenovir
Updated : 5 years, 11 months ago IST
New Delhi [India], June 19 (ANI): CSIR constituent lab CSIR-Central Drug Research Institute (CDRI) Lucknow has received permission for carrying out Phase III trial of antiviral drug Umifenovir, Union Health Minister Dr Harsh Vardhan said on Friday.
Read More
Restricted, emergency use of Remdesivir, Tocilizumab likely for treating C
Updated : 5 years, 12 months ago IST
New Delhi [India], June 11 (ANI): Remdesivir, an antiviral drug and Tocilizumab, an immunomodulator, are being considered by the Union Health Ministry for 'restricted, emergency use' and on 'compassionate grounds' to treat severely ill COVID-19 patients.
Read More
Glenmark to start new phase 3 clinical trial for hospitalised patients of
Updated : 6 years ago IST
Mumbai (Maharashtra) [India], May 26 (ANI): Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential Covid-19 treatment strategy.
Read More